NEW YORK (GenomeWeb News) – The US Federal Trade Commission today said that it has ordered MDS to sell its Arcturus laser microdissection business to Life Technologies as a condition of approving its deal to sell its MDS Analytical Technologies unit to Danaher.

The FTC said that the sale would "resolve FTC charges that Danaher's acquisition of MDS Analytical Technologies would harm competition in the North American market for laser microdissection devices." It noted that Danaher and MDS are two of only four North American suppliers of such devices.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.